Results 221 to 230 of about 557,930 (311)

Ancient and Emerging Nanostructures for Innovations to Fight Head and Neck Cancer. [PDF]

Cells
Kummer N, Acet Ö, Acet BÖ, Blueggel M, Khamis A, Gül D, Knauer SK, Stauber RH.   +7 more
europepmc   +1 more source

How Would You Treat? A Case‐Vignette Study of Provider Treatment Preferences in Human Papillomavirus‐Mediated Oropharyngeal Cancer

Head &Neck, EarlyView.
ABSTRACT Background Current guidelines recommend surgical resection, definitive radiotherapy (RT), or concurrent chemoradiotherapy (CRT) for human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma (OPSCC). This study aimed to provide insight into practice patterns of providers who treat HPV‐associated OPSCC.
Sindhura Sridhar, Michael R. Papazian, Michael C. Topf   +2 more
wiley   +1 more source

Patterns of Influenza Vaccination in Head and Neck Cancer Patients in the United States. [PDF]

Laryngoscope Investig Otolaryngol
Lee MY, Sunwoo JB, Chen MM.
europepmc   +1 more source

Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications

Head &Neck, EarlyView.
ABSTRACT Background Beyond follicular‐derived thyroid carcinomas, lymphomas, and metastatic disease, there are rare pathologies of the thyroid gland that represent a challenge. We report patients with unusual malignancies that mimic similar aggressive cancers. Methods Retrospective case series.
David Z. Allen, S. Mohsen Hosseini, Mark Zafereo, Miriam Lango, Elizabeth Gardner Grubbs, Priyanka Iyer, Shreyaskumar R. Patel, Vinod Ravi, Naifa Lamki Busaidy, Rui Jennifer Wang, Michelle D. Williams, Maria E. Cabanillas, Anastasios Maniakas   +12 more
wiley   +1 more source

Multi-agent chemotherapy for refractory head and neck cancer. [PDF]

J Chin Med Assoc
Ho IW, Chen TH, Chang PM, Tai SK, Chu PY, Lin JC, Yang MH.   +6 more
europepmc   +1 more source

Prognostic Impact of Tumor Stage and Growth Pattern in Sinonasal Adenoid Cystic Carcinoma: A 15‐Year Population‐Based Study

Head &Neck, EarlyView.
ABSTRACT Background Sinonasal adenoid cystic carcinoma (AdCC) has a limited prognosis. This study assesses its incidence and prognostic factors in The Netherlands, focusing on histopathological features. Methods Adult patients diagnosed during 2008–2022 were retrieved through the Netherlands Cancer Registry and the Dutch Pathology Registry.
Lise J. van de Velde, Gerben E. Breimer, Lot A. Devriese, Mischa de Ridder, W. F. Julius Scheurleer, Weibel W. Braunius, Remco de Bree, Boukje A. C. van Dijk, Liza A. Hoveling, Johannes A. Rijken   +9 more
wiley   +1 more source

Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer. [PDF]

Genome Med
Ourailidis I, Ball M, Vogel V, He M, Wang H, Kim SB, Böning S, Wollenberg B, Wolff KD, Steiger K, Mogler C, Duensing A, Duensing S, Schirmacher P, Stenzinger A, Gires O, Kazdal D, Kirchner M, Stögbauer F, Boxberg M, Budczies J.   +20 more
europepmc   +1 more source

A Student‐Led Tele‐Expiratory Muscle Strength Training (EMST) Program for Head and Neck Cancer (HNC) Survivors—A Pilot Implementation Study

Head &Neck, EarlyView.
ABSTRACT Background Expiratory muscle strength training (EMST) is a non‐invasive, evidence‐based treatment that is used to improve swallowing in head and neck cancer (HNC) survivors. This prospective, pilot implementation study evaluated the feasibility, acceptability, and potential clinical effectiveness of a novel student‐led tele‐EMST program for ...
Katrina Blyth, Jessica Tam, Rachelle Robinson, Danielle Stone, Emma S. Wallace   +4 more
wiley   +1 more source

Modeling Financial Insolvency and Income Loss Insurance in Head and Neck Cancer. [PDF]

J Health Econ Outcomes Res
Araujo AV, Bartho MJ, Low GMI, Li RJ.
europepmc   +1 more source

Disparity in the Markers of Affordability Across Targeted‐ and Immune‐Therapy Drugs Used in Head and Neck Cancers

Head &Neck, EarlyView.
ABSTRACT Background The expanding use of systemic therapies for recurrent and metastatic head and neck cancer has raised major concerns regarding affordability and equitable access, particularly across countries with differing income levels and health financing structures.
Arjun Gurmeet Singh, Labani Kole, Richard Sullivan, Shwetabh Sinha, Rathan Shetty, Poonam Joshi, Sudhir Nair, Sarbani Ghosh Laskar, Kumar Prabhash, Pankaj Chaturvedi   +9 more
wiley   +1 more source